JENNA BRANAM: Open Payments
NPI 1083229751 · SIDNEY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,912 in 141 payments from 10 companies in 2025. Trend: 2023 $1,125 · 2024 $1,880 · 2025 $1,912
Food & beverage: $1,912
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 20 | $388 |
| Janssen Pharmaceuticals, Inc | 34 | $340 |
| Lundbeck LLC | 21 | $338 |
| Otsuka America Pharmaceutical, Inc. | 19 | $223 |
| E.R. Squibb & Sons, L.L.C. | 22 | $200 |
| Teva Pharmaceuticals USA, Inc. | 13 | $200 |
| ABBVIE INC. | 4 | $85 |
| Axsome Therapeutics, Inc. | 4 | $66 |
| Vanda Pharmaceuticals Inc. | 3 | $56 |
| Alkermes, Inc. | 1 | $18 |
Products named: INGREZZA, REXULTI, INVEGA SUSTENNA, COBENFY, UZEDY, ABILIFY MAINTENA, ABILIFY ASIMTUFII, VRAYLAR.
Industry payments across OH — which companies pay providers there.
